Plasma adiponectin levels are associated with coronary lesion complexity in men with coronary artery disease.

OBJECTIVES We sought to assess whether plasma adiponectin levels correlate with angiographic coronary lesion complexity in patients with coronary artery disease (CAD). BACKGROUND Metabolic disorders, including diabetes mellitus and metabolic syndrome, are important risk factors for acute cardiovascular events, and adiponectin is a key molecule of metabolic disorders, with anti-atherogenic properties. Low plasma adiponectin levels are associated with CAD and future incidence of myocardial infarction. The involvement of adiponectin in coronary plaque vulnerability, which may be reflected by angiographic complex lesions, remains to be elucidated. METHODS We measured plasma adiponectin levels in 207 men (152 with stable CAD and 55 with acute coronary syndromes [ACS]). Coronary lesions were classified as of simple or complex appearance. RESULTS Plasma adiponectin levels were significantly lower in stable CAD patients with complex coronary lesions (n = 60) than in those with simple lesions (n = 92) (4.14 [range 2.95 to 6.02] vs. 5.27 [range 3.67 to 8.12] microg/ml, p = 0.006). Multiple logistic regression analysis demonstrated that adiponectin level was independently associated with complex lesions (odds ratio 0.514, 95% confidence interval 0.278 to 0.951; p = 0.034). Polytomous logistic regression revealed that adiponectin correlated independently with both single and multiple complex lesions. Among patients with ACS, who had lower adiponectin levels than stable CAD patients, those with multiple complex lesions had significantly lower adiponectin than those with a single complex lesion (3.26 [range 2.26 to 4.46] vs. 4.21 [range 3.36 to 5.41] microg/ml, p = 0.032). CONCLUSIONS Plasma adiponectin levels are significantly associated with coronary lesion complexity in men with CAD. Low adiponectin levels may contribute to coronary plaque vulnerability.

[1]  D. Tousoulis,et al.  Differential progression of complex and smooth stenoses within the same coronary tree in men with stable coronary artery disease. , 1995, Journal of the American College of Cardiology.

[2]  S. Kihara,et al.  Adipocyte-Derived Plasma Protein Adiponectin Acts as a Platelet-Derived Growth Factor-BB–Binding Protein and Regulates Growth Factor–Induced Common Postreceptor Signal in Vascular Smooth Muscle Cell , 2002, Circulation.

[3]  T Nakamura,et al.  Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. , 1999, Circulation.

[4]  Louis E. Teichholz,et al.  Angiographie morphology and the pathogenesis of unstable angina pectoris , 1985 .

[5]  S. Kihara,et al.  Association of Hypoadiponectinemia With Coronary Artery Disease in Men , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[6]  C. Olympios,et al.  C-reactive protein and multiple complex coronary artery plaques in patients with primary unstable angina. , 2002, Atherosclerosis.

[7]  T. Marwick,et al.  A new method of scoring coronary angiograms to reflect extent of coronary atherosclerosis and improve correlation with major risk factors. , 1990, American heart journal.

[8]  E. Braunwald,et al.  Unstable angina. A classification. , 1989, Circulation.

[9]  J. Beckman,et al.  Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I , 2013, European heart journal.

[10]  J. Kaski,et al.  Rapid angiographic progression of coronary artery disease in patients with angina pectoris. The role of complex stenosis morphology. , 1995, Circulation.

[11]  J. Kaski,et al.  Serum neopterin and complex stenosis morphology in patients with unstable angina. , 2000, Journal of the American College of Cardiology.

[12]  J. Kaski,et al.  Angiographic stenosis progression and coronary events in patients with 'stabilized' unstable angina. , 1995, Circulation.

[13]  L. Chen,et al.  The natural history of unheralded complex coronary plaques. , 1996, Journal of the American College of Cardiology.

[14]  E. Brilakis,et al.  Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. , 2005, The New England journal of medicine.

[15]  Cynthia J. Girman,et al.  Plasma adiponectin levels and risk of myocardial infarction in men. , 2004, JAMA.

[16]  V. Fuster,et al.  Angiographic evolution of coronary artery morphology in unstable angina. , 1986, Journal of the American College of Cardiology.

[17]  S. Kihara,et al.  Adipocyte-Derived Plasma Protein, Adiponectin, Suppresses Lipid Accumulation and Class A Scavenger Receptor Expression in Human Monocyte-Derived Macrophages , 2001, Circulation.

[18]  V. Fuster,et al.  Coronary Composition and Macrophage Infiltration in Atherectomy Specimens From Patients With Diabetes Mellitus , 2000, Circulation.

[19]  Antonio Colombo,et al.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. , 2003, Circulation.

[20]  T. Funahashi,et al.  Levels of the adipocyte-derived plasma protein, adiponectin, have a close relationship with atheroma. , 2005, Thrombosis research.

[21]  Y. Shimada,et al.  Implications of plasma concentrations of adiponectin in patients with coronary artery disease , 2004, Heart.

[22]  T Nakamura,et al.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.

[23]  Jukka T Salonen,et al.  The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. , 2002, JAMA.

[24]  V. Fuster,et al.  New aspects in the pathogenesis of diabetic atherothrombosis. , 2004, Journal of the American College of Cardiology.

[25]  S. Kihara,et al.  Adiponectin and Metabolic Syndrome , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[26]  J. Kaski,et al.  Pregnancy-Associated Plasma Protein A and Its Endogenous Inhibitor, the Proform of Eosinophil Major Basic Protein (proMBP), Are Related to Complex Stenosis Morphology in Patients With Stable Angina Pectoris , 2004, Circulation.

[27]  P. Libby.  Molecular bases of the acute coronary syndromes. , 1995, Circulation.

[28]  T Nakamura,et al.  Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[29]  T Nakamura,et al.  An Adipocyte-Derived Plasma Protein, Adiponectin, Adheres to Injured Vascular Walls , 2000, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[30]  S. Kihara,et al.  Adiponectin Specifically Increased Tissue Inhibitor of Metalloproteinase-1 Through Interleukin-10 Expression in Human Macrophages , 2004, Circulation.

[31]  J. Kaski,et al.  C-reactive protein elevation and disease activity in patients with coronary artery disease. , 2004, European heart journal.

[32]  E. Boerwinkle,et al.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. , 2003, Circulation.

[33]  S. Kihara,et al.  Erratum , 2003, Heart.

[34]  J. Ioannidis,et al.  C-Reactive protein concentrations and angiographic characteristics of coronary lesions. , 2001, Clinical chemistry.

[35]  V. Fuster,et al.  Coronary plaque disruption. , 1995, Circulation.

[36]  S. Ellis,et al.  Morphology of left anterior descending coronary territory lesions as a predictor of anterior myocardial infarction: a CASS Registry Study. , 1989, Journal of the American College of Cardiology.

[37]  S. Kihara,et al.  Adiponectin Reduces Atherosclerosis in Apolipoprotein E-Deficient Mice , 2002, Circulation.

[38]  D C Levin,et al.  Significance of the Angiographic Morphology of Localized Coronary Stenoses: Histopathologic Correlations , 1982, Circulation.

[39]  J. Kaski,et al.  Multiple complex stenoses, high neutrophil count and C-reactive protein levels in patients with chronic stable angina. , 2004, Atherosclerosis.

[40]  M. Matsuda,et al.  PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. , 2001, Diabetes.